As of Feb 11
| -0.21 / -2.44%|
The 6 analysts offering 12-month price forecasts for Cardiovascular Systems Inc have a median target of 13.88, with a high estimate of 22.00 and a low estimate of 12.00. The median estimate represents a +65.38% increase from the last price of 8.39.
The current consensus among 8 polled investment analysts is to Buy stock in Cardiovascular Systems Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.